are there natural glp-1 agonists Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential Current Insights, Advantages and Challenges
Description
Research in animal models and population studies suggests GLP-1 receptor agonists may reduce dementia risk and improve cognitive function, but clinical trials are still ongoing
It is important to distinguish between theoretical concerns, findings from animal studies, and actual evidence in human populations
doi: 10.1111/dom.13137
Christopher K Rayner, Adelaide Medical School, The University of Adelaide, Adelaide, SA 5000, Australia
